Research from the Centre of Cancer Immunology which spans more than a decade has informed two new clinical trials investigating the potential of novel monoclonal antibodies to treat solid tumours, such as breast cancer.
Scientists at the Centre for Cancer Immunology have made a breakthrough in understanding why some cancers don’t respond to immunotherapy treatment.
Scientists have discovered that cervical cancer can be divided into two distinct molecular subgroups – one far more aggressive than the other – as part of the largest ‘omics’ study of its kind, led by researchers at UCL and the University of Southampton. Published in Nature Communications, researchers say the breakthrough findings are a ‘major Continued
A new type of cancer treatment developed at Southampton – that it is hoped will significantly improve the success rate of immunotherapy – is undergoing clinical trials for the first time.
A study from the Centre for Cancer Immunology has revealed a potential new target for immunotherapy treatment.
Scientists at the Centre for Cancer Immunology have gained unprecedented new insight into the key properties of an antibody needed to fight off cancer.
Researchers at the Centre for Cancer Immunology are applying an immunotherapy treatment to an often-incurable form of cancer in a new clinical trial opening in Southampton.
Research led by the Centre for Cancer Immunology could help identify patients at risk of rapid progression and resistance to therapy in chronic lymphocytic leukaemia (CLL).
New study highlights the importance of COVID-19 vaccination boosters for cancer patients.
‘Crown-like structures’ surrounding breast tumours in overweight and obese patients could hinder their response to therapy, a new Southampton study has found.